Latest filing published 12 Aug 2026 for Axogen, Inc., €477k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Marc A. Began (board member) discloses dealings in 2 companies, chiefly Abiomed Inc and Axogen, Inc. In total, 19 filings cover trades dated from 25 May 2021 to 10 August 2026.
On the market, this insider has only sold: 5 sales, €4.2M in total. The rest of the record consists of 11 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 12 August 2026, the filings show an option exercise worth €477k in Axogen, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations